Intrinsic Value of S&P & Nasdaq Contact Us

Beam Therapeutics Inc. BEAM NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.86
+34.9%

Beam Therapeutics Inc. (BEAM) has 10 identified peers for comparison in the Healthcare sector. Peers include CRBU, CRSP, DNA, EDIT, FATE, NTLA and others.

BEAM has a market capitalization of $3.09B, compared to an average peer market cap of $12.38B. BEAM is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message